Trial intelligence / Profile preview

Apomine in Postmenopausal Women With Osteoporosis or Low Bone Mass

NCT00078026Phase 2Terminated

Sponsor
Sanofi
Start
Aug 2003
Countries
1
01

Overview

A Phase 2 trial of apomine in osteoporosis, osteopenia, sponsored by Sanofi. Started Aug 2003; status: terminated.

02

Drugs

apomine
03

Conditions

osteoporosisosteopenia

Beyond the preview

Go deeper on NCT00078026.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00078026.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call